CN105111479A - Method for modifying fluorinated siloxane acrylate material of rigid gas-permeable corneal contact lens - Google Patents
Method for modifying fluorinated siloxane acrylate material of rigid gas-permeable corneal contact lens Download PDFInfo
- Publication number
- CN105111479A CN105111479A CN201510551357.3A CN201510551357A CN105111479A CN 105111479 A CN105111479 A CN 105111479A CN 201510551357 A CN201510551357 A CN 201510551357A CN 105111479 A CN105111479 A CN 105111479A
- Authority
- CN
- China
- Prior art keywords
- contact lens
- rigid gas
- acrylate material
- aqueous solution
- modifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 24
- -1 siloxane acrylate Chemical class 0.000 title 1
- 238000009832 plasma treatment Methods 0.000 claims abstract description 25
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 24
- 239000007864 aqueous solution Substances 0.000 claims abstract description 22
- 229920002521 macromolecule Polymers 0.000 claims abstract description 11
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 38
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 claims description 28
- 229910021529 ammonia Inorganic materials 0.000 claims description 19
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 13
- 239000001301 oxygen Substances 0.000 claims description 13
- 229910052760 oxygen Inorganic materials 0.000 claims description 13
- 125000004386 diacrylate group Chemical group 0.000 claims description 11
- 239000007789 gas Substances 0.000 claims description 11
- 238000002715 modification method Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 6
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims 1
- 229950004354 phosphorylcholine Drugs 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 16
- 108090000623 proteins and genes Proteins 0.000 abstract description 16
- 238000001179 sorption measurement Methods 0.000 abstract description 10
- 238000004381 surface treatment Methods 0.000 abstract description 9
- 230000008021 deposition Effects 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 8
- 229910021641 deionized water Inorganic materials 0.000 description 8
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 230000003592 biomimetic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 231100000989 no adverse effect Toxicity 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000004382 visual function Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 2
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 208000021921 corneal disease Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 229910001872 inorganic gas Inorganic materials 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
Landscapes
- Eyeglasses (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
Abstract
本发明涉及一种改性硬性透气性角膜接触镜材料的方法,公开了一种硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料通过等离子体处理、接枝实现对其的改性方法。该方法包括以下步骤:对硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料进行等离子体处理;将处理后的材料浸泡在仿生大分子水溶液中,得改性硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料。本发明采用等离子体表面处理方法对硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料进行处理,再将具有高亲水性、良好生物相容性及防止蛋白质吸附性质的仿生大分子接枝到材料表面,提高其亲水性、使泪液较易铺展开,解决其初戴舒适性差的问题,长时间佩戴不易引起蛋白质的沉积,延长配戴时间及改善配戴舒适度。
The invention relates to a method for modifying a rigid gas-permeable corneal contact lens material, and discloses a method for modifying a rigid gas-permeable corneal contact lens fluorosiloxane acrylate material through plasma treatment and grafting. The method comprises the following steps: performing plasma treatment on the fluorosilicone acrylate material of the rigid gas-permeable contact lens; immersing the treated material in a bionic macromolecule aqueous solution to obtain the modified rigid gas-permeable contact lens fluorosilicone Alkacrylate material. The invention adopts the plasma surface treatment method to treat the fluorosiloxane acrylate material of the rigid gas-permeable contact lens, and then grafts the bionic macromolecule with high hydrophilicity, good biocompatibility and protein adsorption prevention property to the The surface of the material improves its hydrophilicity, makes it easier for tears to spread out, and solves the problem of poor comfort when wearing it for the first time. Long-term wearing is not easy to cause protein deposition, prolonging the wearing time and improving the wearing comfort.
Description
技术领域technical field
本发明涉及一种改性硬性透气性角膜接触镜材料的方法,特别涉及一种硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料通过等离子体处理、接枝实现对其的改性方法。该方法可以提高传统氟硅氧烷丙烯酸酯材料的亲水性、使泪液较易铺展开,解决其初戴舒适性差的问题,长时间佩戴后不易引起泪液中蛋白质的沉积,实现延长配戴时间及改善配戴舒适度。所得的改性材料可应用于硬性透气性角膜接触镜的性能改善、优化。The invention relates to a method for modifying a rigid gas-permeable contact lens material, in particular to a method for modifying a rigid gas-permeable contact lens fluorosiloxane acrylate material through plasma treatment and grafting. This method can improve the hydrophilicity of traditional fluorosilicone acrylate materials, make tears spread out more easily, and solve the problem of poor comfort when wearing them for the first time. It is not easy to cause protein deposition in tears after long-term wearing, and prolongs the wearing time. and improve wearing comfort. The obtained modified material can be applied to the performance improvement and optimization of the rigid gas permeable contact lens.
背景技术Background technique
角膜接触镜是一种主要用于矫正各类屈光不正(包括近视、远视、散光和老视)的医用光学器具,问世已有百多年。由于它与角膜直接接触,学术界将其命名为“角膜接触镜”。不论是矫正视力、美化眼睛色泽还是用于治疗角膜疾病,目前已有无数人享受到配戴角膜接触镜带来的好处。据统计,我国配戴角膜接触镜者约占总人口的3%,美国、日本等国家占10%。随着角膜接触镜生产工艺和材料的不断发展和改良,配戴角膜接触镜的人口比例具有不断上升的趋势,角膜接触镜的用途也越来越多。Contact lens is a medical optical device mainly used to correct various refractive errors (including myopia, hyperopia, astigmatism and presbyopia), and has been around for more than 100 years. Because it is in direct contact with the cornea, the academic circles named it "contact lens". Whether it's correcting vision, beautifying eye color, or treating corneal disease, countless people are already enjoying the benefits of wearing contact lenses. According to statistics, people who wear contact lenses in my country account for about 3% of the total population, and countries such as the United States and Japan account for 10%. With the continuous development and improvement of contact lens production technology and materials, the proportion of the population wearing contact lenses has a rising trend, and the use of contact lenses is also increasing.
硬性角膜接触镜材料的发展,经历了从初期的玻璃、聚甲基丙烯酸甲酯(PMMA)等传统的硬性角膜接触镜材料到醋酸丁酯纤维素(CBA)、氟硅氧烷丙烯酸酯(FSA)、碳氟化合物(FC)等可透气的硬性角膜接触镜材料的过程。硬性角膜接触镜具有比较坚硬、吸水性极小、不易被水润湿、配戴的舒适度不高等缺点。The development of hard contact lens materials has gone through the process from the initial glass, polymethyl methacrylate (PMMA) and other traditional hard contact lens materials to butyl cellulose acetate (CBA), fluorosilicone acrylate (FSA) ), fluorocarbon (FC) and other gas permeable rigid contact lens materials. Rigid contact lenses have disadvantages such as relatively hard, extremely small water absorption, not easily wetted by water, and low wearing comfort.
表面改性是改善材料表面性能最直接、最有效的途径,与其它方法相比,等离子体技术有工艺简单、成本低、无污染、效率高、反应温度低、处理的均匀性好等优点。直接的等离子体表面处理是将材料暴露于非聚合性的无机气体产生的等离子体中,利用等离子体中的能量粒子和活性物种轰击材料表面,与材料表面发生反应,使其表面产生特定的官能团,引起材料结构发生变化,从而对材料进行表面改性,改善材料的表面性能。等离子体表面处理会使材料表面产生刻蚀和粗糙化。但是,简单的等离子体表面处理只能在短时间内赋予材料一定的表面性能,由于等离子体处理效果的时效性,在材料表面引入的功能基团会逐渐向表面内运动和翻转。为获得持久的表面改性效果,大多还需对材料作进一步的表面修饰。Surface modification is the most direct and effective way to improve the surface properties of materials. Compared with other methods, plasma technology has the advantages of simple process, low cost, no pollution, high efficiency, low reaction temperature, and good treatment uniformity. Direct plasma surface treatment is to expose the material to the plasma generated by non-polymerizable inorganic gas, use the energy particles and active species in the plasma to bombard the surface of the material, react with the surface of the material, and generate specific functional groups on the surface , causing changes in the structure of the material, thereby modifying the surface of the material and improving the surface properties of the material. Plasma surface treatment causes etching and roughening of the material surface. However, simple plasma surface treatment can only endow the material with certain surface properties in a short period of time. Due to the timeliness of the plasma treatment effect, the functional groups introduced on the surface of the material will gradually move into the surface and turn over. In order to obtain a lasting surface modification effect, most of the materials need further surface modification.
发明内容Contents of the invention
为了克服上述现有技术的缺点与不足,本发明的目的在于提供一种硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料的改性方法。In order to overcome the above-mentioned shortcomings and deficiencies of the prior art, the object of the present invention is to provide a method for modifying the fluorosilicone acrylate material of a rigid gas-permeable contact lens.
本发明的目的通过下述方案实现:The object of the present invention is achieved through the following solutions:
一种硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料的改性方法,包括以下具体步骤:A method for modifying a rigid gas-permeable contact lens fluorosilicone acrylate material, comprising the following specific steps:
(1)对硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料(FSARGPCL)进行等离子体处理;(1) Plasma treatment of fluorosilicone acrylate material (FSARGPCL) for rigid gas permeable contact lenses;
(2)将处理后的材料浸泡在仿生大分子水溶液中,得改性硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料。(2) Soak the processed material in the bionic macromolecule aqueous solution to obtain the modified rigid gas permeable contact lens fluorosilicone acrylate material.
步骤(1)中所述的等离子体可为氨等离子体或氧等离子体。The plasma described in step (1) can be ammonia plasma or oxygen plasma.
步骤(1)中所述的等离子体处理的时间优选为30~300s,放电功率优选为50~200W。The plasma treatment time in step (1) is preferably 30-300s, and the discharge power is preferably 50-200W.
更优选的,步骤(1)中所述的等离子体处理的时间为120s,放电功率为100W。More preferably, the plasma treatment time in step (1) is 120s, and the discharge power is 100W.
为了更好地实现本发明,步骤(1)中所述的硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料可为切割的1mm左右的薄片。In order to better realize the present invention, the rigid gas-permeable contact lens fluorosilicone acrylate material described in step (1) can be a cut sheet of about 1 mm.
优选地,步骤(1)中的所述的硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料在切割后可进行抛光,超声清洗,去离子水洗后常温干燥。Preferably, the rigid gas-permeable contact lens fluorosilicone acrylate material in step (1) can be polished after cutting, ultrasonically cleaned, washed with deionized water, and then dried at room temperature.
更优选的,上述超声清洗是指用超声波清洗器清洗10~20min,最优选为15min。More preferably, the above-mentioned ultrasonic cleaning refers to cleaning with an ultrasonic cleaner for 10-20 minutes, most preferably 15 minutes.
步骤(2)中所述的仿生大分子水溶液优选为2-甲基丙烯酰氧乙基磷酸胆碱(MPC)水溶液、聚乙二醇二丙烯酸酯(PEGDA)水溶液或聚乙二醇(PEG)水溶液中的一种。The biomimetic macromolecule aqueous solution described in step (2) is preferably 2-methacryloyloxyethyl phosphorylcholine (MPC) aqueous solution, polyethylene glycol diacrylate (PEGDA) aqueous solution or polyethylene glycol (PEG) One of the aqueous solutions.
优选的,步骤(2)中所述的仿生大分子水溶液为2-甲基丙烯酰氧乙基磷酸胆碱(MPC)水溶液或聚乙二醇二丙烯酸酯(PEGDA)水溶液。2-甲基丙烯酰氧乙基磷酸胆碱和聚乙二醇二丙烯酸酯均是具有高亲水性及良好生物相容性的仿生大分子,它们的结构类似于生物膜的结构,用于生物材料表面修饰可显著改善材料的亲水性及生物相容性,减少材料表面对蛋白质的吸附。Preferably, the biomimetic macromolecule aqueous solution described in step (2) is 2-methacryloyloxyethyl phosphorylcholine (MPC) aqueous solution or polyethylene glycol diacrylate (PEGDA) aqueous solution. 2-Methacryloyloxyethylphosphorylcholine and polyethylene glycol diacrylate are biomimetic macromolecules with high hydrophilicity and good biocompatibility. Their structures are similar to those of biological membranes. They are used in Surface modification of biomaterials can significantly improve the hydrophilicity and biocompatibility of materials, and reduce the adsorption of proteins on the surface of materials.
更优选的,步骤(2)中所述的聚乙二醇二丙烯酸酯(PEGDA)的分子量为4000~10000。More preferably, the polyethylene glycol diacrylate (PEGDA) described in step (2) has a molecular weight of 4000-10000.
步骤(2)中所述的仿生大分子水溶液的浓度优选为0.01~0.1wt%。The concentration of the biomimetic macromolecule aqueous solution described in step (2) is preferably 0.01-0.1 wt%.
步骤(2)中所述的浸泡优选为浸泡2~4h。The soaking described in step (2) is preferably soaking for 2-4 hours.
步骤(2)中所述的浸泡优选为边浸泡边搅拌。The soaking described in step (2) is preferably stirred while soaking.
步骤(2)中所述的得到的改性硬性透气性角膜接触镜氟硅氧烷丙烯酸酯材料可利用去离子水冲洗并常温干燥进行后处理。The modified rigid gas permeable contact lens fluorosilicone acrylate material obtained in step (2) can be rinsed with deionized water and dried at room temperature for post-treatment.
本发明的机理为:Mechanism of the present invention is:
本发明采用等离子体表面处理方法对硬性透气性角膜接触镜(RGPCL)氟硅氧烷丙烯酸酯(FSA)材料进行表面处理,改善了角膜接触镜表面的亲水性,由于等离子体处理效果的时效性,在材料表面引入的功能基团会逐渐向表面内运动和翻转,为获得持久的表面改性效果,本发明将具有高亲水性、良好生物相容性及防止蛋白质吸附性质的仿生大分子2-甲基丙烯酰氧乙基磷酸胆碱(MPC)或聚乙二醇二丙烯酸酯(PEGDA)接枝到FSARGPCL角膜接触镜材料表面,进一步提高角膜接触镜表面的亲水性,减少了接触镜表面对蛋白质的吸附,达到了理想的表面性能。The present invention adopts plasma surface treatment method to carry out surface treatment to rigid gas permeable contact lens (RGPCL) fluorosilicone acrylate (FSA) material, improves the hydrophilic property of contact lens surface, because the aging of plasma treatment effect The functional groups introduced on the surface of the material will gradually move and turn over on the surface. In order to obtain a lasting surface modification effect, the present invention will have bionic macromolecules with high hydrophilicity, good biocompatibility and protein adsorption prevention The molecule 2-methacryloyloxyethylphosphorylcholine (MPC) or polyethylene glycol diacrylate (PEGDA) is grafted onto the surface of FSARGPCL contact lens material to further improve the hydrophilicity of the contact lens surface and reduce the Adsorption of protein on the contact lens surface achieves ideal surface properties.
本发明相对于现有技术,具有如下的优点及有益效果:Compared with the prior art, the present invention has the following advantages and beneficial effects:
(1)本发明提出的表面改性方法,可以提高传统FSA材料的亲水性、使泪液较易铺展开,解决其初戴舒适性差的问题,长时间佩戴后不易引起泪液中蛋白质的沉积,实现延长配戴时间及改善配戴舒适度。(1) The surface modification method proposed by the present invention can improve the hydrophilicity of the traditional FSA material, make the tears easier to spread, and solve the problem of poor comfort when wearing it at the beginning, and it is not easy to cause protein deposition in the tears after wearing for a long time. Achieve extended wearing time and improve wearing comfort.
(2)本发明提出的表面改性方法,并没有改变角膜接触镜的本体性能,改性前后接触镜的折射率没有明显变化。(2) The surface modification method proposed by the present invention does not change the bulk performance of the contact lens, and the refractive index of the contact lens does not change significantly before and after modification.
(3)本发明所采用的加工工艺简单,成本较低,有利于规模生产。(3) The processing technology adopted in the present invention is simple, and the cost is relatively low, which is conducive to large-scale production.
附图说明Description of drawings
图1为氨等离子体处理前后FSARGPCL角膜接触镜表面的SEM照片。Figure 1 is the SEM photographs of the surface of FSARGPCL contact lens before and after ammonia plasma treatment.
图2为氧等离子体处理前后FSARGPCL角膜接触镜表面的SEM照片。Figure 2 is the SEM photographs of the surface of the FSARGPCL contact lens before and after oxygen plasma treatment.
图3为氨等离子体接枝MPC前后FSARGPCL角膜接触镜表面的SEM照片。Fig. 3 is the SEM photograph of the surface of FSARGPCL contact lens before and after ammonia plasma grafting MPC.
图4为氧等离子体接枝MPC前后FSARGPCL角膜接触镜表面的SEM照片。Fig. 4 is the SEM photograph of the surface of FSARGPCL contact lens before and after oxygen plasma grafting MPC.
图5为氨等离子体接枝MPC前后FSARGPCL角膜接触镜的折射率比较曲线。Figure 5 is a comparison curve of the refractive index of the FSARGPCL contact lens before and after ammonia plasma grafting MPC.
图6为氨等离子体接枝MPC前后FSARGPCL角膜接触镜表面的蛋白质吸附量。Figure 6 shows the amount of protein adsorption on the surface of FSARGPCL contact lens before and after ammonia plasma grafting MPC.
图7为氧等离子体接枝MPC前后FSARGPCL角膜接触镜的折射率比较曲线。Figure 7 is a comparison curve of the refractive index of the FSARGPCL contact lens before and after oxygen plasma grafting MPC.
图8为氧等离子体接枝MPC前后FSARGPCL角膜接触镜表面的蛋白质吸附量。Figure 8 shows the amount of protein adsorption on the surface of FSARGPCL contact lens before and after oxygen plasma grafting MPC.
图9为氨等离子体接枝PEGDA前后FSARGPCL角膜接触镜的折射率比较曲线。Fig. 9 is a comparison curve of the refractive index of the FSARGPCL contact lens before and after ammonia plasma grafting PEGDA.
图10为氨等离子体接枝PEGDA前后FSARGPCL角膜接触镜表面的蛋白质吸附量。Figure 10 shows the amount of protein adsorption on the surface of FSARGPCL contact lens before and after ammonia plasma grafting PEGDA.
具体实施方式Detailed ways
下面结合实施例和附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。The present invention will be further described in detail below with reference to the examples and drawings, but the implementation of the present invention is not limited thereto.
下列实施例中所用试剂均可从市场上购得。All reagents used in the following examples can be purchased from the market.
实施例1Example 1
以氨等离子体处理为表面处理方法,2-甲基丙烯酰氧乙基磷酸胆碱(MPC)为接枝分子,步骤如下:Ammonia plasma treatment is used as the surface treatment method, and 2-methacryloyloxyethyl phosphorylcholine (MPC) is used as the grafted molecule. The steps are as follows:
(1)将FSARGPCL角膜接触镜材料(BostonXO,温州医学院)切割成1mm左右的薄片,并进行抛光,用数控超声波清洗器清洗15min,去离子水冲洗干净,常温下干燥,保存备用。(1) The FSARGPCL contact lens material (BostonXO, Wenzhou Medical College) was cut into thin slices of about 1 mm, polished, cleaned with a digitally controlled ultrasonic cleaner for 15 minutes, rinsed with deionized water, dried at room temperature, and stored for later use.
(2)在氨等离子体处理120s,放电功率为100W下,对FSARGPCL角膜接触镜材料进行等离子体处理。(2) Under the ammonia plasma treatment for 120s and the discharge power of 100W, plasma treatment was performed on the FSARGPCL contact lens material.
(3)将处理后的材料浸泡在浓度为0.02wt%的2-甲基丙烯酰氧乙基磷酸胆碱(MPC)水溶液中3h,期间用磁力搅拌器不停地搅拌。(3) Soak the treated material in a 0.02wt% 2-methacryloyloxyethylphosphorylcholine (MPC) aqueous solution for 3 hours, during which time a magnetic stirrer is used to continuously stir.
(4)用去离子水冲洗接触镜材料表面3次,常温下干燥,保存。(4) Rinse the surface of the contact lens material 3 times with deionized water, dry at room temperature, and store.
图1为氨等离子体处理前后FSARGPCL角膜接触镜表面的SEM照片,图3为氨等离子体接枝MPC前后FSARGPCL角膜接触镜表面的SEM照片,改性前后接触镜表面相对平整,说明在一定的改性条件下氨等离子体处理不会对接触镜表面形态产生很大影响。Figure 1 is the SEM photograph of the surface of FSARGPCL contact lens before and after ammonia plasma treatment, and Figure 3 is the SEM photograph of the surface of FSARGPCL contact lens before and after ammonia plasma grafting with MPC. Ammonia plasma treatment under neutral conditions does not have a great effect on the surface morphology of contact lenses.
图5为氨等离子体接枝MPC前后FSARGPCL角膜接触镜的折射率比较曲线。接枝前后FSARGPCL角膜接触镜的折射率并没有明显变化,并没有改变角膜接触镜的本体性能,说明改性方法对角膜接触镜最基本的视功能没有不利影响。Figure 5 is a comparison curve of the refractive index of the FSARGPCL contact lens before and after ammonia plasma grafting MPC. The refractive index of FSARGPCL contact lenses did not change significantly before and after grafting, and the bulk performance of contact lenses did not change, which indicated that the modification method had no adverse effect on the most basic visual function of contact lenses.
图6为氨等离子体接枝MPC前后FSARGPCL角膜接触镜表面的蛋白质吸附量,经改性后的角膜接触镜降低了蛋白质在镜片上的沉积。Figure 6 shows the amount of protein adsorption on the surface of FSARGPCL contact lens before and after ammonia plasma grafting MPC, the modified contact lens reduces the deposition of protein on the lens.
实施例2Example 2
以氧等离子体处理为表面处理方法,2-甲基丙烯酰氧乙基磷酸胆碱(MPC)为接枝分子,步骤如下:Oxygen plasma treatment is used as the surface treatment method, and 2-methacryloyloxyethyl phosphorylcholine (MPC) is used as the graft molecule, and the steps are as follows:
(1)将FSARGPCL角膜接触镜材料(BostonXO,温州医学院)切割成1mm左右的薄片,并进行抛光,用数控超声波清洗器清洗15min,去离子水冲洗干净,常温下干燥,保存备用。(1) The FSARGPCL contact lens material (BostonXO, Wenzhou Medical College) was cut into thin slices of about 1 mm, polished, cleaned with a digitally controlled ultrasonic cleaner for 15 min, rinsed with deionized water, dried at room temperature, and stored for later use.
(2)在氧等离子体处理120s,放电功率为100W下,对FSARGPCL角膜接触镜材料进行等离子体处理。(2) Under oxygen plasma treatment for 120s and discharge power of 100W, plasma treatment was performed on FSARGPCL contact lens material.
(3)将处理后的材料浸泡在浓度为0.05wt%的2-甲基丙烯酰氧乙基磷酸胆碱(MPC)水溶液中2h,期间用磁力搅拌器不停地搅拌。(3) Soak the treated material in an aqueous solution of 2-methacryloyloxyethylphosphorylcholine (MPC) with a concentration of 0.05wt% for 2 hours, and stir continuously with a magnetic stirrer during this period.
(4)用去离子水冲洗接触镜材料表面3次,常温下干燥,保存。(4) Rinse the surface of the contact lens material 3 times with deionized water, dry at room temperature, and store.
图2为氧等离子体处理前后FSARGPCL角膜接触镜表面的SEM照片,图4为氧等离子体接枝MPC前后FSARGPCL角膜接触镜表面的SEM照片,改性前后接触镜表面相对平整,说明在一定的改性条件下氧等离子体处理不会对接触镜表面形态产生很大影响。Figure 2 is the SEM photograph of the surface of the FSARGPCL contact lens before and after oxygen plasma treatment, and Figure 4 is the SEM photograph of the surface of the FSARGPCL contact lens before and after oxygen plasma grafted with MPC. Oxygen plasma treatment under neutral conditions does not significantly affect the surface morphology of contact lenses.
图7为氧等离子体接枝MPC前后FSARGPCL角膜接触镜的折射率比较曲线,接枝前后FSARGPCL角膜接触镜的折射率并没有明显变化,并没有改变角膜接触镜的本体性能。说明此改性方法对角膜接触镜最基本的视功能没有不利影响。Figure 7 is the comparison curve of the refractive index of the FSARGPCL contact lens before and after oxygen plasma grafting MPC, the refractive index of the FSARGPCL contact lens did not change significantly before and after grafting, and did not change the bulk performance of the contact lens. It shows that this modification method has no adverse effect on the most basic visual function of contact lenses.
图8为氧等离子体接枝MPC前后FSARGPCL角膜接触镜表面的蛋白质吸附量,经改性后的角膜接触镜降低了蛋白质在镜片上的沉积。Figure 8 shows the amount of protein adsorption on the surface of the FSARGPCL contact lens before and after oxygen plasma grafting MPC, the modified contact lens reduces the deposition of protein on the lens.
实施例3Example 3
以氨等离子体处理为表面处理方法,聚乙二醇二丙烯酸酯(PEGDA)为接枝分子,步骤如下:Ammonia plasma treatment is used as the surface treatment method, polyethylene glycol diacrylate (PEGDA) is used as the graft molecule, and the steps are as follows:
(1)将FSARGPCL角膜接触镜材料(BostonXO,温州医学院)切割成1mm左右的薄片,并进行抛光,用数控超声波清洗器清洗15min,去离子水冲洗干净,常温下干燥,保存备用。(1) The FSARGPCL contact lens material (BostonXO, Wenzhou Medical College) was cut into thin slices of about 1 mm, polished, cleaned with a digitally controlled ultrasonic cleaner for 15 minutes, rinsed with deionized water, dried at room temperature, and stored for later use.
(2)在氨等离子体处理120s,放电功率为100W下,对FSARGPCL角膜接触镜材料进行等离子体处理。(2) Under the ammonia plasma treatment for 120s and the discharge power of 100W, plasma treatment was performed on the FSARGPCL contact lens material.
(3)将处理后的材料浸泡在浓度为0.01wt%的聚乙二醇二丙烯酸酯10000(PEGDA10000)水溶液中3h,期间用磁力搅拌器不停地搅拌。(3) Soak the treated material in a polyethylene glycol diacrylate 10000 (PEGDA10000) aqueous solution with a concentration of 0.01 wt% for 3 hours, and stir continuously with a magnetic stirrer during this period.
按上述步骤(1)~(3)用聚乙二醇二丙烯酸酯4000(PEGDA4000)为接枝分子对FSARGPCL角膜接触镜材料进行改性。According to the above steps (1)-(3), polyethylene glycol diacrylate 4000 (PEGDA4000) was used as the graft molecule to modify the FSARGPCL contact lens material.
(4)用去离子水冲洗接触镜材料表面3次,常温下干燥,保存。(4) Rinse the surface of the contact lens material 3 times with deionized water, dry at room temperature, and store.
图9为氨等离子体接枝PEGDA前后FSARGPCL角膜接触镜的折射率比较曲线,接枝前后FSARGPCL角膜接触镜的折射率并没有明显变化,并没有改变角膜接触镜的本体性能。说明此改性方法对角膜接触镜最基本的视功能没有不利影响。Figure 9 is a comparison curve of the refractive index of the FSARGPCL contact lens before and after ammonia plasma grafting with PEGDA. The refractive index of the FSARGPCL contact lens did not change significantly before and after grafting, and the bulk performance of the contact lens did not change. It shows that this modification method has no adverse effect on the most basic visual function of contact lenses.
图10为氨等离子体接枝PEGDA前后FSARGPCL角膜接触镜表面的蛋白质吸附量,经改性后的角膜接触镜降低了蛋白质在镜片上的沉积。Figure 10 shows the amount of protein adsorption on the surface of the FSARGPCL contact lens before and after ammonia plasma grafting with PEGDA. The modified contact lens reduces the deposition of protein on the lens.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510551357.3A CN105111479A (en) | 2015-08-31 | 2015-08-31 | Method for modifying fluorinated siloxane acrylate material of rigid gas-permeable corneal contact lens |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510551357.3A CN105111479A (en) | 2015-08-31 | 2015-08-31 | Method for modifying fluorinated siloxane acrylate material of rigid gas-permeable corneal contact lens |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105111479A true CN105111479A (en) | 2015-12-02 |
Family
ID=54659615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510551357.3A Pending CN105111479A (en) | 2015-08-31 | 2015-08-31 | Method for modifying fluorinated siloxane acrylate material of rigid gas-permeable corneal contact lens |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105111479A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110194846A (en) * | 2019-06-26 | 2019-09-03 | 江苏彩康隐形眼镜有限公司 | The preparation method of the modified and its colored Ortho-K in Ortho-K surface |
CN112375247A (en) * | 2020-12-02 | 2021-02-19 | 中国科学院合肥物质科学研究院 | Corneal contact lens treatment method based on amphiphilic composite gradient functional membrane |
CN115197522A (en) * | 2022-06-10 | 2022-10-18 | 甘肃康视丽隐形眼镜有限公司 | High-water-content high-oxygen-permeability silicon hydrogel, corneal contact lens and preparation method of corneal contact lens |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101386684A (en) * | 2008-10-21 | 2009-03-18 | 东南大学 | Method for preparing highly hydrophilic film on the surface of medical polyurethane material |
CN101726864A (en) * | 2009-11-30 | 2010-06-09 | 温州医学院眼视光研究院 | Method for modifying hydrophility of plasmons at surface of fluorine and silicon hard corneal contact lens |
CN103333357A (en) * | 2013-07-02 | 2013-10-02 | 江苏耀华医疗器械科技有限公司 | Preparation method of high hydrophilic medical PVC catheter surface |
-
2015
- 2015-08-31 CN CN201510551357.3A patent/CN105111479A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101386684A (en) * | 2008-10-21 | 2009-03-18 | 东南大学 | Method for preparing highly hydrophilic film on the surface of medical polyurethane material |
CN101726864A (en) * | 2009-11-30 | 2010-06-09 | 温州医学院眼视光研究院 | Method for modifying hydrophility of plasmons at surface of fluorine and silicon hard corneal contact lens |
CN103333357A (en) * | 2013-07-02 | 2013-10-02 | 江苏耀华医疗器械科技有限公司 | Preparation method of high hydrophilic medical PVC catheter surface |
Non-Patent Citations (1)
Title |
---|
赵连娜: "硬性透气性角膜接触镜表面等离子体改性研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110194846A (en) * | 2019-06-26 | 2019-09-03 | 江苏彩康隐形眼镜有限公司 | The preparation method of the modified and its colored Ortho-K in Ortho-K surface |
CN112375247A (en) * | 2020-12-02 | 2021-02-19 | 中国科学院合肥物质科学研究院 | Corneal contact lens treatment method based on amphiphilic composite gradient functional membrane |
CN115197522A (en) * | 2022-06-10 | 2022-10-18 | 甘肃康视丽隐形眼镜有限公司 | High-water-content high-oxygen-permeability silicon hydrogel, corneal contact lens and preparation method of corneal contact lens |
CN115197522B (en) * | 2022-06-10 | 2024-02-23 | 甘肃康视丽隐形眼镜有限公司 | High-water-content high-oxygen-permeability silicon hydrogel, cornea contact lens and preparation method of cornea contact lens |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3647093B2 (en) | Hydrophilized oxygen permeable contact lens and method for producing the same | |
CA2938393C (en) | Lens solution, contact lens, and production method therefor | |
JP2707497B2 (en) | Ophthalmic implant and manufacturing method thereof | |
CN103908700A (en) | Decellularization cornea preparation method | |
DE50107710D1 (en) | METHOD FOR THE DEZELLULARIZATION OF FOREIGN MATERIAL FOR THE PRODUCTION OF BIOPROTHESES | |
CN105111479A (en) | Method for modifying fluorinated siloxane acrylate material of rigid gas-permeable corneal contact lens | |
CN107376020B (en) | A kind of artificial ligament surface modification method | |
JP2009223158A (en) | Ophthalmic lens and method for manufacturing ophthalmic lens | |
JPH084618B2 (en) | Manufacturing method of antithrombogenic material | |
CN113980185A (en) | Amorphous silver-containing long-acting antibacterial hydrogel dressing with photo-crosslinking curing function and preparation method thereof | |
EP1853330A1 (en) | Methods for providing biomedical devices with hydrophilic antimicrobial coatings | |
JPH06502782A (en) | Improved ophthalmic implants and their manufacturing methods | |
CN113769169A (en) | A kind of anticoagulation and promoting cell adhesion biological valve material and preparation method thereof | |
FR2836044A1 (en) | COMPOSITION FOR REPAIR AND SKIN HEALING EXCLUSIVELY INCLUDING A TRUE PHYSICAL HYDROGEL OF CHITOSAN | |
US10328644B2 (en) | Method for introducing an active compound into a soft hydrated contact lens | |
CN1232623C (en) | Low ionic strength ophthalmic compositions | |
WO1997037269A1 (en) | Contact lens cleaning solution and method for cleaning contact lenses using the same | |
JP2000010055A (en) | Hydrophilic lens for eye and its production | |
JPS6027965B2 (en) | How to remove dirt from contact lenses | |
RU2077873C1 (en) | Synthetic corneal lens and method for their manufacturing | |
JPH0580279A (en) | Soft contact lens | |
JPWO2011108520A1 (en) | SKIN MATERIAL AND METHOD FOR PRODUCING SKIN MATERIAL | |
CN119613793A (en) | A surface treatment method for hard gas permeable corneal contact lens material | |
TW201719242A (en) | Contact lens material and contact lens | |
CN110755687A (en) | Method for decellularizing mammalian cornea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151202 |